Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : World Heart Corp - WHRT and TSE/WHT -- Ignore unavailable to you. Want to Upgrade?

To: SwampDogg who wrote (288)	7/23/1999 12:18:00 PM
From: Dan Hamilton	Respond to of 500

One thing we should keep in mind is that there are also very promising advances being made in drug treatments for heart failure. Here is one that was reported a few days ago in newspapers, and appears to be very cheap and effective... The New England Journal of Medicine Aldosterone and Spironolactone in Heart Failure "The overall risks of death, death due to progressive heart failure, and sudden death from cardiac causes were reduced by approximately 30 percent among spironolactone-treated patients, prompting the early termination of the study. There were similar reductions in the risk of hospitalization for cardiac causes, and a significantly higher percentage of patients in the spironolactone group than in the placebo group had an improvement in functional status." nejm.org